Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-25

Clinical Trial Update: Rotigaptide in Endothelial Dysfunction? [NA]

View source ↗

Summary

A completed clinical trial evaluating Rotigaptide for endothelial dysfunction in patients with ischaemic heart disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rotigaptide

Snippet

Sponsor: University of Edinburgh | Conditions: Ischaemic Heart Diseases | NA | Status: COMPLETED